HomeGeneticsConditionType A insulin resistance syndrome
Back to Condition
Type A insulin resistance syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Type A insulin resistance syndrome

Type A insulin resistance syndrome is a rare genetic disorder characterized by severe insulin resistance, often leading to diabetes mellitus and specific hormonal abnormalities in females.

Overview

This syndrome is part of a spectrum of inherited severe insulin resistance disorders. It is considered the mildest form, as symptoms often do not appear until puberty or later and are generally not life-threatening.

Symptoms

  • Insulin resistance: The body’s tissues do not respond properly to insulin, impairing blood glucose regulation and leading to diabetes mellitus.
  • Female-specific features: Many females experience primary amenorrhea (failure to begin menstruation by age 16) or light, irregular periods. They may also develop ovarian cysts and hirsutism (excessive body hair growth).
  • Skin changes: Both males and females may develop acanthosis nigricans, where skin in body folds becomes thick, dark, and velvety.
  • Weight: Unlike many other forms of insulin resistance, affected females are typically not overweight.
  • Male-specific features: Symptoms in males are often more subtle, sometimes presenting only as low blood sugar (hypoglycemia) or diabetes mellitus in adulthood.

Causes

The syndrome is caused by mutations in the INSR gene, which provides instructions for making the insulin receptor. These receptors are found on the outer membrane of cells and are responsible for binding to insulin to trigger essential cell functions. Mutations result in a faulty receptor that cannot transmit signals properly, leading to severe insulin resistance despite the presence of insulin in the bloodstream.

Inheritance

Type A insulin resistance syndrome can be inherited in either an autosomal dominant or, less commonly, an autosomal recessive pattern. In dominant cases, one copy of the altered gene is sufficient to cause the disorder, while in recessive cases, both copies of the gene must be mutated.

Frequently Asked Questions

Diagnosis typically begins with a clinical assessment of insulin resistance signs (elevated fasting insulin, acanthosis nigricans, menstrual irregularities) and a glucose tolerance test. A definitive diagnosis requires sequencing of the INSR gene, which can be done through a targeted next‑generation sequencing panel. Results are usually available within 2–4 weeks, after which a specialist can interpret the mutation’s pathogenicity and discuss inheritance implications. How can patients with Type A insulin resistance syndrome reduce their risk of developing type 2 diabetes and its complications?::Early and aggressive glucose control is key. Most clinicians start with metformin to improve insulin sensitivity, add thiazolidinediones or GLP‑1 receptor agonists if needed, and monitor HbA1c every 3–6 months. Regular screening for diabetic retinopathy, nephropathy, and cardiovascular disease (annual eye exams, yearly microalbuminuria tests, and lipid panels) helps catch complications early. What specific dietary changes and exercise routines are most effective for improving insulin sensitivity in this condition?::A low‑glycemic‑index diet rich in whole grains, legumes, non‑starchy vegetables, and lean proteins helps keep blood sugars steady. Aim for 150 minutes of moderate aerobic activity (e.g., brisk walking) plus 2–3 sessions of resistance training per week to increase muscle mass, which enhances glucose uptake. Avoid high‑fat, processed foods and limit sugary drinks. How does Type A insulin resistance syndrome affect fertility, and what options exist for women who wish to conceive?::Many affected women experience primary amenorrhea or irregular cycles due to ovarian dysfunction. Hormonal therapy (e.g., combined oral contraceptives or gonadotropin‑releasing hormone agonists) can restore regular cycles, and insulin‑sensitizing agents like metformin improve ovulation rates. For those who still struggle, assisted reproductive technologies such as in‑vitro fertilization with controlled ovarian hyperstimulation are effective, especially when combined with metabolic optimization.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA